# Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation

> **NCT00428233** · PHASE1 · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 65 (actual)

## Conditions studied

- Chronic Lymphocytic Leukemia

## Interventions

- **PROCEDURE:** Leukemia cell harvest

## Key facts

- **NCT ID:** NCT00428233
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2020-04-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00428233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00428233, "Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00428233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*